查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636685

器官保存解决方案市场预测至 2030 年：按器官类型、解决方案类型、分销管道、应用和地区进行的全球分析

Organ Preservation Solutions Market Forecasts to 2030 - Global Analysis By Organ Type (Kidneys, Liver, Heart, Lungs, Pancreas and Other Organ Types), Solution Type, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球器官保存解决方案市场预计在 2024 年将达到 2.73 亿美元，到 2030 年预计将达到 4.213 亿美元，预测期内的复合年增长率为 7.5%。

器官保存溶液是一种特殊的液体，用于在器官从捐赠者体内取出到移植到接受者体内期间维持器官的活力和功能。这些解决方案可防止细胞损伤、减少代谢活动并保护组织免受缺血性损伤，使器官仍适合移植。透过保持器官凉爽和防止通常导致器官劣化的生化过程，它对于维持器官结构和功能至关重要。

根据美国人口普查局的数据，到 2024 年，美国20% 的人口预计将年龄在 65 岁或以上，导致需要器官移植的与老龄化相关的疾病发生率很高。

器官衰竭发生率增加

由于老化、慢性病和生活方式相关的健康问题等因素导致的器官衰竭发病率不断增加，大大推动了器官移植的需求。这推动了器官保存解决方案市场的成长。随着需要移植的器官越来越多，长期维持器官活力的重要性推动了器官保存技术和解决方案的进步，从而促进了市场的扩张。

器官供应有限

市场上器官供应有限带来了重大挑战，包括增加器官移植的等待时间以及增加需要器官移植的患者的风险。这种短缺导致对次优保存方法的依赖，从而降低器官存活率和移植成功率。此外，由于需求远远超过供应，医疗保健系统被迫根据标准对患者进行优先排序，这往往使他们处于最脆弱的境地。

老年人口不断增加

老化人口的不断增长是器官保存解决方案需求的主要驱动力。由于老年人更容易出现与器官相关的健康问题并需要器官移植，对有效的器官保存方法的需求正在迅速增加。这种人口变化促进了器官保存技术的进步，确保了器官移植更长的存活时间和更好的结果。与老龄化相关的疾病发生率的增加和对移植解决方案的需求是该市场的主要成长要素。

治疗费用高昂

该市场上的高昂手术费用可能会对医疗服务的可近性和可负担性造成重大障碍，尤其是在资源匮乏的地区。这些成本可能会限制先进保存技术的可用性，并阻碍器官的及时运输和移植。这可能导致器官移植成功率降低并破坏器官捐赠系统的整体效率，从而导致更长的等待时间和更高的死亡率。

COVID-19 的影响：

由于健康和安全问题，COVID-19 疫情推迟了选择性手术并减少了器官捐赠，严重扰乱了市场。医院面临资源短缺，器官运输因封锁和旅行限製而受到阻碍。这些挑战导致移植积压，影响了患者的治疗结果并减少了对保存解决方案的整体需求。此外，疫情也为这些关键医疗产品的供应链带来了压力。

器官移植领域预计将成为预测期内最大的领域

预计预测期内器官移植部分将占据市场占有率。有效的器官保存对于维持运输过程中的器官活力和成功移植至关重要。随着器官捐赠者的不断增加，创新保存解决方案的需求也随之增加，尤其是肾臟、肝臟和心臟等需求量大的器官。市场的成长与提高移植成功率和器官寿命的保存方法的进步密切相关。

预计预测期内生物防腐领域将以最高的复合年增长率成长。

预计预测期内生物防腐领域将以最高的复合年增长率成长。这种方法涉及冷冻保存或低温保存技术，以保护器官免受冷冻和低温造成的伤害。生物保存透过延长器官储存时间、减少缺血性损伤和提高移植成功率来确保器官移植获得更好的结果。其日益普及正在推动器官保存技术的创新和市场成长。

比最大的地区

预计预测期内北美地区将占据最大的市场占有率。该地区是研究和开发保存技术的温床，包括低温和常温。政府对器官移植的措施和资助进一步推动了市场的成长。北美对高效保存解决方案的需求很高，这是由于提高移植成功率和减少器官排斥的需求。

复合年增长率最高的地区：

由于器官移植需求的不断增加，预计亚太地区在预测期内将实现最高的成长率。由于器官衰竭以及糖尿病、心臟病等慢性疾病的发生率不断上升，器官移植的需求也日益增加。此外，机器灌注和冷藏溶液等先进保存方法的发展提高了器官在运输和储存过程中的活力。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业进行基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球器官保存解决方案市场（按器官类型）

  • 肾
  • 肝
  • 心
  • 肺
  • 胰臟
  • 其他器官类型

6. 全球器官保存解决方案市场（依解决方案类型）

  • 防静电解决方案
    • 威斯康辛大学 (UW) 解决方案
    • 柯林斯解决方案
    • Celsior 解决方案
    • 託管解决方案
  • 动态储存解决方案
    • 常温机灌注（NMP）
    • 低温灌注机 (HMP)

7. 全球器官保存解决方案市场按分销管道划分

  • 直接销售
  • 分销商/批发商
  • 网上销售与电子商务

8. 全球器官保存解决方案市场（按应用）

  • 器官移植
  • 医学研发
  • 药物测试
  • 生物保存
  • 临床和诊断
  • 器官获取和运输
  • 其他应用

9. 全球器官保存解决方案市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Thermo Fisher Scientific
  • Merck
  • Fisher Scientific
  • TSE Systems
  • Sorin Group
  • Eurobio Scientific
  • Baxter International
  • Medtronic
  • Teva Pharmaceuticals
  • Asahi Kasei Medical
  • Hemonetics
  • Organ Recovery Systems
  • TransMedics
  • Perfusion Solutions
  • Stemcell Technologies
Product Code: SMRC28326

According to Stratistics MRC, the Global Organ Preservation Solutions Market is accounted for $273.0 million in 2024 and is expected to reach $421.3 million by 2030 growing at a CAGR of 7.5% during the forecast period. Organ preservation solutions are specialized fluids designed to maintain the viability and function of organs during the period between their removal from a donor and transplantation into a recipient. These solutions help prevent cellular damage, reduce metabolic activity, and protect tissues from ischemic injury, ensuring that the organ remains suitable for transplantation. They are critical in preserving the organ's structure and function for extended periods, typically by cooling the organ and preventing biochemical processes that could lead to organ deterioration.

According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants.

Market Dynamics:

Driver:

Increasing incidence of organ failure

The increasing incidence of organ failure, driven by factors such as aging populations, chronic diseases, and lifestyle-related health issues, has significantly boosted the demand for organ transplantation. This, in turn, has fueled the growth of the organ preservation solutions market. As more organs are needed for transplantation, the importance of preserving organ viability for longer durations has led to advancements in preservation technologies and solutions, contributing to market expansion.

Restraint:

Limited availability of organs

The limited availability of organs in the market poses significant challenges, including increased organ transplant waiting times and heightened risks for patients in need. This scarcity leads to a reliance on suboptimal preservation methods, which may reduce organ viability and transplant success rates. Additionally, the shortage contributes to ethical concerns, as demand far exceeds supply, forcing healthcare systems to prioritize patients based on criteria, often leaving vulnerable groups at a disadvantage.

Opportunity:

Growing geriatric population

The growing geriatric population is significantly driving the demand for organ preservation solutions. As the elderly are more prone to organ-related health issues and require organ transplants, the need for effective preservation methods has surged. This demographic shift is spurring advancements in organ preservation technologies, ensuring longer viability and better outcomes for organ transplants. The increasing incidence of age-related diseases and the need for transplantation solutions are key growth factors in this market.

Threat:

High cost of procedures

The high cost of procedures in the market can create significant barriers to accessibility and affordability, particularly in low-resource settings. These expenses may limit the availability of advanced preservation technologies, hindering the timely transport and transplantation of organs. As a result, the success rates of organ transplants could decline, and the overall efficiency of organ donation systems may be compromised, leading to prolonged waiting times and increased mortality rates.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the market by delaying elective surgeries and reducing organ donations due to health and safety concerns. Hospitals faced resource shortages, and transportation of organs was hindered by lockdowns and travel restrictions. These challenges led to a backlog in transplants, affecting patient outcomes and reducing the overall demand for preservation solutions. Furthermore, the pandemic strained the supply chain for these critical medical products.

The organ transplantation segment is expected to be the largest during the forecast period

The organ transplantation segment is anticipated to account for the largest market share during the projection period. Effective organ preservation is vital for maintaining organ viability during transportation, ensuring successful transplants. As the number of organ donors grows, the need for innovative preservation solutions intensifies, especially for high-demand organs like kidneys, livers, and hearts. The market's growth is closely tied to advancements in preservation methods that enhance transplant success rates and organ longevity.

The biopreservation segment is expected to have the highest CAGR during the forecast period

The biopreservation segment is expected to have the highest CAGR during the extrapolated period. This approach involves cryopreservation or hypothermic preservation techniques, which protect organs from damage caused by freezing or low temperatures. Biopreservation ensures better outcomes in organ transplantation by prolonging the shelf life of organs, reducing ischemic damage, and improving transplant success rates. Its growing adoption drives innovation and market growth in organ preservation technologies.

Region with largest share:

North America region is anticipated to account for the largest market share during the forecast period. The region benefits from robust research and development in preservation technologies, including hypothermic and normothermic techniques. Government initiatives and funding for organ transplantation further support market growth. North America's high demand for efficient preservation solutions is driven by the need to enhance transplant success rates and reduce organ rejection.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period due to the increasing demand for organ transplants. The demand for organ transplants is increasing due to the rising prevalence of organ failure and chronic diseases like diabetes and heart disease. Additionally, the development of advanced preservation methods, such as machine perfusion and cold storage solutions, has led to improved organ viability during transportation and storage.

Key players in the market

Some of the key players in Organ Preservation Solutions market include Thermo Fisher Scientific, Merck, Fisher Scientific, TSE Systems, Sorin Group, Eurobio Scientific, Baxter International, Medtronic, Teva Pharmaceuticals, Asahi Kasei Medical, Hemonetics, Organ Recovery Systems, TransMedics, Perfusion Solutions and Stemcell Technologies.

Key Developments:

In August 2024, Paragonix Technologies has acquired by Getinge, one of the world's leading medical technology companies. A global industry leader in organ transplantation, Paragonix is recognized for the advanced, FDA-approved organ transportation solutions it provides to safeguard the secure transportation of donor organs.

In June 2024, Devyser Diagnostics AB (publ) announced that the company has expanded its exclusive collaboration and distribution agreement with Thermo Fisher Scientific, giving Thermo Fisher exclusive rights to commercialize, under combined brands, Devyser's post-transplant portfolio of NGS products globally.

Organ Types Covered:

  • Kidneys
  • Liver
  • Heart
  • Lungs
  • Pancreas
  • Other Organ Types

Solution Types Covered:

  • Static Preservation Solutions
  • Dynamic Preservation Solutions

Distribution Channels Covered:

  • Direct Sales
  • Distributors/Wholesalers
  • Online Sales & E-Commerce

Applications Covered:

  • Organ Transplantation
  • Medical Research & Development
  • Pharmaceutical Testing
  • Biopreservation
  • Clinical and Diagnostic
  • Organ Recovery & Transportation
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Organ Preservation Solutions Market, By Organ Type

  • 5.1 Introduction
  • 5.2 Kidneys
  • 5.3 Liver
  • 5.4 Heart
  • 5.5 Lungs
  • 5.6 Pancreas
  • 5.7 Other Organ Types

6 Global Organ Preservation Solutions Market, By Solution Type

  • 6.1 Introduction
  • 6.2 Static Preservation Solutions
    • 6.2.1 University of Wisconsin (UW) solution
    • 6.2.2 Collins solution
    • 6.2.3 Celsior solution
    • 6.2.4 Custodiol solution
  • 6.3 Dynamic Preservation Solutions
    • 6.3.1 Normothermic machine perfusion (NMP)
    • 6.3.2 Hypothermic machine perfusion (HMP)

7 Global Organ Preservation Solutions Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Distributors/Wholesalers
  • 7.4 Online Sales & E-Commerce

8 Global Organ Preservation Solutions Market, By Application

  • 8.1 Introduction
  • 8.2 Organ Transplantation
  • 8.3 Medical Research & Development
  • 8.4 Pharmaceutical Testing
  • 8.5 Biopreservation
  • 8.6 Clinical and Diagnostic
  • 8.7 Organ Recovery & Transportation
  • 8.8 Other Applications

9 Global Organ Preservation Solutions Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific
  • 11.2 Merck
  • 11.3 Fisher Scientific
  • 11.4 TSE Systems
  • 11.5 Sorin Group
  • 11.6 Eurobio Scientific
  • 11.7 Baxter International
  • 11.8 Medtronic
  • 11.9 Teva Pharmaceuticals
  • 11.10 Asahi Kasei Medical
  • 11.11 Hemonetics
  • 11.12 Organ Recovery Systems
  • 11.13 TransMedics
  • 11.14 Perfusion Solutions
  • 11.15 Stemcell Technologies

List of Tables

  • Table 1 Global Organ Preservation Solutions Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Organ Preservation Solutions Market Outlook, By Organ Type (2022-2030) ($MN)
  • Table 3 Global Organ Preservation Solutions Market Outlook, By Kidneys (2022-2030) ($MN)
  • Table 4 Global Organ Preservation Solutions Market Outlook, By Liver (2022-2030) ($MN)
  • Table 5 Global Organ Preservation Solutions Market Outlook, By Heart (2022-2030) ($MN)
  • Table 6 Global Organ Preservation Solutions Market Outlook, By Lungs (2022-2030) ($MN)
  • Table 7 Global Organ Preservation Solutions Market Outlook, By Pancreas (2022-2030) ($MN)
  • Table 8 Global Organ Preservation Solutions Market Outlook, By Other Organ Types (2022-2030) ($MN)
  • Table 9 Global Organ Preservation Solutions Market Outlook, By Solution Type (2022-2030) ($MN)
  • Table 10 Global Organ Preservation Solutions Market Outlook, By Static Preservation Solutions (2022-2030) ($MN)
  • Table 11 Global Organ Preservation Solutions Market Outlook, By University of Wisconsin (UW) solution (2022-2030) ($MN)
  • Table 12 Global Organ Preservation Solutions Market Outlook, By Collins solution (2022-2030) ($MN)
  • Table 13 Global Organ Preservation Solutions Market Outlook, By Celsior solution (2022-2030) ($MN)
  • Table 14 Global Organ Preservation Solutions Market Outlook, By Custodiol solution (2022-2030) ($MN)
  • Table 15 Global Organ Preservation Solutions Market Outlook, By Dynamic Preservation Solutions (2022-2030) ($MN)
  • Table 16 Global Organ Preservation Solutions Market Outlook, By Normothermic machine perfusion (NMP) (2022-2030) ($MN)
  • Table 17 Global Organ Preservation Solutions Market Outlook, By Hypothermic machine perfusion (HMP) (2022-2030) ($MN)
  • Table 18 Global Organ Preservation Solutions Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 19 Global Organ Preservation Solutions Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 20 Global Organ Preservation Solutions Market Outlook, By Distributors/Wholesalers (2022-2030) ($MN)
  • Table 21 Global Organ Preservation Solutions Market Outlook, By Online Sales & E-Commerce (2022-2030) ($MN)
  • Table 22 Global Organ Preservation Solutions Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Organ Preservation Solutions Market Outlook, By Organ Transplantation (2022-2030) ($MN)
  • Table 24 Global Organ Preservation Solutions Market Outlook, By Medical Research & Development (2022-2030) ($MN)
  • Table 25 Global Organ Preservation Solutions Market Outlook, By Pharmaceutical Testing (2022-2030) ($MN)
  • Table 26 Global Organ Preservation Solutions Market Outlook, By Biopreservation (2022-2030) ($MN)
  • Table 27 Global Organ Preservation Solutions Market Outlook, By Clinical and Diagnostic (2022-2030) ($MN)
  • Table 28 Global Organ Preservation Solutions Market Outlook, By Organ Recovery & Transportation (2022-2030) ($MN)
  • Table 29 Global Organ Preservation Solutions Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.